| 2, 4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death J Grundlingh, PI Dargan, M El-Zanfaly, DM Wood Journal of medical toxicology 7, 205-212, 2011 | 574 | 2011 |
| Purchasing ‘legal highs’ on the Internet—is there consistency in what you get? S Davies, DM Wood, G Smith, J Button, J Ramsey, R Archer, DW Holt, ... QJM: An International Journal of Medicine 103 (7), 489-493, 2010 | 300 | 2010 |
| New psychoactive substances: a review and updates A Shafi, AJ Berry, H Sumnall, DM Wood, DK Tracy Therapeutic advances in psychopharmacology 10, 2045125320967197, 2020 | 286 | 2020 |
| Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity DM Wood, S Davies, M Puchnarewicz, J Button, R Archer, H Ovaska, ... Journal of Medical Toxicology 6, 327-330, 2010 | 267 | 2010 |
| Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change PI Dargan, S Albert, DM Wood Qjm 103 (11), 875-879, 2010 | 259 | 2010 |
| The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use SS Kalsi, DM Wood, PI Dargan Emerging Health Threats Journal 4 (1), 7107, 2011 | 213 | 2011 |
| Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone DM Wood, SL Greene, PI Dargan Emergency medicine journal 28 (4), 280-282, 2011 | 204 | 2011 |
| Case series of individuals with analytically confirmed acute mephedrone toxicity DM Wood, S Davies, SL Greene, J Button, DW Holt, J Ramsey, PI Dargan Clinical Toxicology 48 (9), 924-927, 2010 | 197 | 2010 |
| The pharmacology and toxicology of the synthetic cathinone mephedrone (4‐methylmethcathinone) PI Dargan, R Sedefov, A Gallegos, DM Wood Drug testing and analysis 3 (7‐8), 454-463, 2011 | 190 | 2011 |
| Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products S Hudson, J Ramsey, L King, S Timbers, S Maynard, PI Dargan, ... Journal of analytical toxicology 34 (5), 252-260, 2010 | 178 | 2010 |
| Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN) AM Dines, DM Wood, C Yates, F Heyerdahl, KE Hovda, I Giraudon, ... Clinical Toxicology 53 (9), 893-900, 2015 | 167 | 2015 |
| The rise in legal highs: prevalence and patterns in the use of illegal drugs and first-and second-generation “legal highs” in South London gay dance clubs F Measham, DM Wood, PI Dargan, K Moore Journal of Substance Use 16 (4), 263-272, 2011 | 159 | 2011 |
| Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment DN Bateman, R Carroll, J Pettie, T Yamamoto, MEMO Elamin, L Peart, ... British journal of clinical pharmacology 78 (3), 610-618, 2014 | 155 | 2014 |
| Gadolinium deposition and the potential for toxicological sequelae–A literature review of issues surrounding gadolinium‐based contrast agents KA Layne, PI Dargan, JRH Archer, DM Wood British journal of clinical pharmacology 84 (11), 2522-2534, 2018 | 150 | 2018 |
| Novel psychoactive substances: classification, pharmacology and toxicology PI Dargan, DM Wood Academic Press, 2021 | 143 | 2021 |
| Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies JW Dear, JI Clarke, B Francis, L Allen, J Wraight, J Shen, PI Dargan, ... The lancet Gastroenterology & hepatology 3 (2), 104-113, 2018 | 143 | 2018 |
| Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury ADB Vliegenthart, JM Shaffer, JI Clarke, LEJ Peeters, A Caporali, ... Scientific reports 5 (1), 15501, 2015 | 143 | 2015 |
| Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine DM Wood, S Davies, M Puchnarewicz, A Johnston, PI Dargan European journal of clinical pharmacology 68, 853-856, 2012 | 143 | 2012 |
| Novel psychoactive substances: types, mechanisms of action, and effects DK Tracy, DM Wood, D Baumeister Bmj 356, 2017 | 142 | 2017 |
| Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study SL Greene, I Gawarammana, DM Wood, AL Jones, PI Dargan Intensive care medicine 33, 2019-2024, 2007 | 139 | 2007 |
